Octreotid-Mepha LA 10 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
7680671540017
CH-67154
H01CB02
07.16.2.
Active substances:
1 / 3
google
Details
- Product number
- 6715401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: octreotidum 10 mg ut octreotidi acetas, poly(lactidum-co-glycolidum), mannitolum, pro vitro. Solvens: carmellosum natricum corresp. natrium 1.512 mg, mannitolum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Octreotid-Mepha LA 10 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
octreotidum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
natrium
|
1.512 MG | Substance | HBESI |
|
octreotidi acetas
|
- | Substance | WIZUS |
|
mannitolum
|
- | Substance | HNIDK |
|
poly(lactidum-co-glycolidum)
|
- | Substance | HNIDK |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67154
- Drug name
- Octreotid-Mepha LA, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
- Galenic form
- PULMS
- ATC Code
- H01CB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/07/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OCTREOTID Mepha LA subst sèche 10 mg c solv
- Description (DE)
- OCTREOTID Mepha LA Trockensub 10 mg c Solv
- Narcotic (BTM)
- No